Impax Laboratories, Actavis Holdco Facing Antitrust Class Action
Last Updated on May 8, 2018
International Union of Operating Engineers Local 30 Benefits Fund v. Impax Laboratories, Inc. et al
Filed: January 13, 2017 ◆§ 2:17-cv-00205-CMR
A proposed class action against the drug manufacturers listed below claims the entities unlawfully conspired to 'fix, maintain, and/or stabilize drug prices.
A proposed class action against the drug manufacturers listed below claims the entities unlawfully conspired to “fix, maintain, and/or stabilize the prices of” the generic Lidicaine/Prilocaine, a topical anesthetic:
- Impax Laboratories, Inc.
- Sandoz, Inc.
- Fougera Pharmaceuticals, Inc.
- Hi-Tech Pharmacal Co., Inc.
- Akorn, Inc.
- Actavis Holdco U.S., Inc.
The 73-page lawsuit alleges the defendants’ conspiracy was put into motion by “direct company-to-company contacts” within the generic drug industry. Citing a 2014 U.S. Department of Justice investigation, the complaint says the defendants’ alleged conduct endangered human lives.
Hair Relaxer Lawsuits
Women who developed ovarian or uterine cancer after using hair relaxers such as Dark & Lovely and Motions may now have an opportunity to take legal action.
Read more here: Hair Relaxer Cancer Lawsuits
Stay Current
Sign Up For
Our Newsletter
New cases and investigations, settlement deadlines, and news straight to your inbox.
Before commenting, please review our comment policy.